No Data
No Data
Bankrupt PhaseBio Pharma Finds Buyers for Secondary Assets After Auction -- Market Talk
1601 ET - Publicly traded PhaseBio Pharmaceuticals, which has already reached a deal to sell its key drug program during its bankruptcy, says it has also found proposed buyers for its secondary assets
SFJ Pharmaceuticals Announces Closing of Transfer of Bentracimab Assets From PhaseBio Pharmaceuticals
SFJ Pharmaceuticals ("SFJ" or the "company") today announced the closing of the sale and transfer of assets related to Bentracimab from PhaseBio Pharmaceuticals, Inc. ("PhaseBio") to SFJ. The sale and transfer was
Delisting of Securities of PhaseBio Pharmaceuticals, Inc.; Zovio Inc.; Fast Radius, Inc.; and Kismet Acquisition Three Corp. From The Nasdaq Stock Market
NEW YORK, Dec. 20, 2022 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of PhaseBio Pharmaceuticals, Inc. PhaseBio Pharmaceuticals, Inc.'s common stock was suspended on
PhaseBio Pharmaceuticals (NASDAQ:PHAS) Trading Up 7%
PhaseBio Pharmaceuticals, Inc. (NASDAQ:PHAS – Get Rating) shares were up 7% during trading on Wednesday . The stock traded as high as $0.11 and last traded at $0.10. Approximately 455,938 shares chan
Bankrupt PhaseBio Identifies Chiesi as Lead Bidder for Bentracimab Assets
By Becky Yerak Chiesi Farmaceutici SpA has been named as the lead bidder for the key assets of PhaseBio Pharmaceuticals Inc., a publicly traded drug developer that is in chapter 11 bankruptcy. Phase
Express News | News On PhaseBio Pharmaceuticals Inc. (PHAS) Now Under PHASQ
No Data
Lax13 : You can’t buy it
praneeth Kepa : Can buy?